| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68c9c6dbc224eefae2cb402ecceb28be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81ab7ff4bc463bbc54ebcb1b961d36ec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2015-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e01b9f361d761bb2c7cd819c741a75c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42f514383772f2b67df5b91b4eacbeb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69b0e443de5a8b30542eec8a3948c6dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e8320610314580f088c14b17bd526c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90d5241d658006d9a75bb46e99d04400 |
| publicationDate |
2016-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016063969-A1 |
| titleOfInvention |
Hemagglutinin-binding peptide |
| abstract |
The present invention address the problem of providing a hemagglutinin-binding peptide from which can be obtained an anti influenza virus effect that is stronger than that of preexisting peptides. Provided is a hemagglutinin-binding peptide, or the like, containing a polypeptide that comprises any of amino acid sequences (i) to (iv). (i) Thr-MeGly-Asp-MePhe-MePhe-Ser-MeSer-His-Tyr-Thr-Val-Pro-Arg (SEQ ID NO. 1). (ii) Arg-Val-Ser-MePhe-Thr-Tyr-MePhe-MeSer-Tyr-Thr-Pro-Ser (SEQ ID NO. 2). (iii) An amino acid sequence obtained by deleting, adding, or substituting one or more amino acids in SEQ ID NO. 1 or 2. (iv) An amino acid sequence having at least 90% sequence identity with SEQ ID NO. 1 or 2. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018038168-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023145860-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020171028-A1 |
| priorityDate |
2014-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |